
Promax Biotechnology Private Limited
Founded in February 2025 and headquartered in Tamil Nadu, India.
Founded in February 2025 and headquartered in Tamil Nadu, India.
Promax Biotechnology Private Limited (PBPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 February 2025 ( 11 days old ). Its registered office is in Coimbatore, Tamil Nadu, India.
The Company is engaged in the Professional Services Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sudhakaran Ramanujam and Vignesh Murthy serve as directors at the Company.
Coimbatore, Tamil Nadu, India
+91-XXXXXXXXXX
-
U72100TZ2025PTC033685
033685
Private Limited Indian Non-Government Company
21 Feb 2025
-
-
Unlisted
Roc Coimbatore
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sudhakaran Ramanujam ![]() | Director | 21-Feb-2025 | Current |
Vignesh Murthy | Director | 21-Feb-2025 | Current |
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Promax Biotechnology's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Promax Biotechnology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Promax Biotechnology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Promax Biotechnology's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sudhakaran Krishna Ramanujam was appointed as a Director was appointed as a Director on 21 Feb 2025 & has been associated with this company since 11 days .
Vignesh Murthy was appointed as a Director was appointed as a Director on 21 Feb 2025 & has been associated with this company since 11 days .
Promax Biotechnology Private Limited was registered on 21 Feb 2025 with Roc Coimbatore & aged 11 days as per MCA records.
Promax Biotechnology Private Limited was incorporated on 21 Feb 2025.
The authorized share capital of Promax Biotechnology Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Promax Biotechnology Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Promax Biotechnology Private Limited is Flat No A-22, Door No.263 Dr. Ambedker Road India, Coimbatore North, Tamil Nadu, 641025.
The corporate identification number (CIN) of Promax Biotechnology Private Limited is U72100TZ2025PTC033685 and the company number is 033685 as per Ministry of Corporate Affairs (MCA).